TOPORS Inhibitors

TOPORS inhibitors belong to a class of chemical compounds that act to modulate the activity of TOPORS, an enzyme with dual ubiquitin and SUMO E3 ligase activities. TOPORS (topoisomerase I-binding arginine/serine-rich protein) plays a critical role in regulating protein homeostasis and maintaining genomic stability. As an E3 ligase, it catalyzes the transfer of ubiquitin or SUMO (small ubiquitin-like modifiers) to specific target proteins, thereby marking them for degradation or altering their function. Ubiquitination typically signals proteins for degradation via the proteasome, while SUMOylation influences protein interactions, localization, and stability. TOPORS inhibitors aim to disrupt the normal function of this enzyme, either by preventing the conjugation of ubiquitin/SUMO to substrate proteins or by modifying the enzyme's activity to impact its regulation of proteostasis and genomic integrity.

These inhibitors are typically designed to interfere with the binding sites or catalytic mechanisms involved in the enzyme's activity. By altering the ubiquitination or SUMOylation pathways, TOPORS inhibitors can cause changes in the stability, folding, or turnover of numerous proteins that are substrates of TOPORS. Given the enzyme's role in diverse cellular processes like DNA damage repair, transcriptional regulation, and cell cycle progression, inhibiting its function can have widespread consequences on cell physiology. Understanding and targeting TOPORS enzymatic pathways provide insights into molecular biology, especially concerning post-translational modifications and the mechanisms governing protein regulation.